Form 4: Clover Health Director Thomas L. Tran Acquires 60,975 Shares Through RSU Grant

Director Thomas L. Tran acquired 60,975 shares of Clover Health Class A Common Stock through a restricted stock unit grant that vests on January 6, 2026.

Summary

• Thomas L. Tran, a director at Clover Health Investments, Corp., acquired 60,975 shares of Class A Common Stock.
• The acquisition was through a grant of time-based restricted stock units (RSUs).
• The RSUs will vest in full on January 6, 2026, one year after the grant date.
• The vesting is contingent upon Mr. Tran's continued service as a director through the vesting date.
• The transaction was reported on January 8, 2025.

Sentiment

Score: 7

Explanation: The document reflects a standard transaction of a director receiving stock as part of their compensation, which is generally viewed positively as it aligns their interests with shareholders. There are no negative implications.

Positives

• The acquisition of shares by a director demonstrates confidence in the company's future.
• The vesting schedule aligns the director's interests with the long-term performance of the company.

Risks

• The vesting of the RSUs is contingent on the director's continued service, which introduces a risk of forfeiture if the director leaves the company before the vesting date.

Future Outlook

The director's continued service is required for the RSUs to vest on January 6, 2026.

Industry Context

This is a standard practice for incentivizing and aligning the interests of directors with the company's performance.

Comparison to Industry Standards

• Granting restricted stock units to directors is a common practice across the industry to align their interests with shareholders.
• Many companies use similar vesting schedules, often tied to continued service, to ensure long-term commitment from directors.
• The size of the grant is within the typical range for director compensation packages, but the specific value depends on the company's stock price.

Stakeholder Impact

• The transaction has a positive impact on shareholders as it aligns the director's interests with the company's long-term success.
• The transaction has no direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Clover Health, Director, Thomas L. Tran, Restricted Stock Units, RSU, Share Acquisition, Class A Common Stock, Vesting